Prostate Cancer Screening Plant City FL

Prostate cancer screening consists of diagnostic tests that can assist with early detection of prostate cancer. Screening may involve a digital rectal exam, prostate-sspecific antigen (PSA) blood test, or a transrectal ultrasound. See below to learn more and to gain access to qualified oncologists in Plant City, FL who provide prostate cancer screening.

Sandra J Sha
(863) 603-4776
1730 Lakeland Hills Blvd
Lakeland, FL
William Smithson Roberts, MD
863-680-7879
1600 Lakeland Hills Blvd
Lakeland, FL
Luis Alberto Franco
(863) 603-4776
1730 Lakeland Hills Blvd
Lakeland, FL
Antonio Trindade
(863) 284-5040
1730 Lakeland Hills Blvd
Lakeland, FL
Kamal Haider, MD
863-284-5040
1730 Lakeland Hills Blvd
Lakeland, FL
Helen Chan
(863) 603-6565
3525 Lakeland Hills Blvd
Lakeland, FL
Robert H Cassel, MR
863-603-6565
3525 Lakeland Hills Blvd
Lakeland, FL
Madhavi Venigalla
(863) 603-6565
3525 Lakeland Hills Blvd
Lakeland, FL
James Ward Jakub, MD
863-603-6565
3525 Lakeland Hills Blvd
Lakeland, FL
Solange Pendas, MD
3525 Lakeland Hills Blvd
Lakeland, FL
Data Provided by:
  

All about the PSA Test

The PSA (Prostate-Specific Antigen) test is one of two primary screening tools for prostate cancer. This simple blood test measures the level of PSA, a protein produced in the prostate, present in a man's body. Men typically have an initial PSA screening at 50, or earlier if there's a family history of prostate cancer.

Physicians measure PSA in nanograms per milliliter. An elevated PSA doesn't diagnose cancer and doesn't mean a man has prostate cancer; it just suggests further evaluation. Other medical conditions can also raise PSA levels. A PSA test and additional diagnostic tools help detect small tumors, however, experts say it does not necessarily reduce a man's chance of dying of prostate cancer.

An increase in PSA is the strongest single predictor of prostate cancer risk, and a high PSA score followed by a lower PSA score is not uncommon, even in men who do have cancer. However, PSA progression does predict poor overall survival rates in men with mestacized prostate cancer (meaning it has spread beyond the prostate). The PSA test is actually a better predictor of prostate cancer risk in African-American men with family histories compared to European- American men.

There is controversy over the value of PSA screenings. This spring, researchers released the results of a large-scale study that began in 1992 to evaluate whether or not the PSA test benefited men. In the subsequent media coverage of the results, the news varied widely depending on who was doing the reporting...

Click here to read more from Quality Health